By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Sorrento (SRNE) Announces Closing Of Public Offering Of Common Stock 4/20/2017 7:32:53 AM
Sorrento (SRNE) Announces Pricing of Public Offering Of Common Stock 4/13/2017 11:19:46 AM
Sorrento (SRNE) Announces Proposed Public Offering Of Common Stock 4/13/2017 11:05:24 AM
Sorrento (SRNE) Anti-CEA CAR-T Demonstrates Promising Clinical Activity And Safety In Phase Ib Clinical Trial 4/4/2017 6:37:57 AM
Sorrento (SRNE) And Wildcat Announce Resolution 3/20/2017 11:05:30 AM
Sorrento (SRNE) Subsidiary, Scilex, Announces Key Endpoints Met In The European Union Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 1/9/2017 8:25:06 AM
Sorrento (SRNE) Subsidiary, Scilex Announces Key Endpoints Met In Pivotal Bioequivalence Clinical Study For Its Lead Product, ZTlido 12/5/2016 6:55:43 AM
Sorrento (SRNE)'s TNK Therapeutics Provides Progress Update For Its Anti-CD38 And CD123 CAR-T Programs For Treatment Of Hematological Malignancies 12/1/2016 11:47:31 AM
Sorrento (SRNE) Secures $75 Million Loan Facility 11/29/2016 9:43:10 AM
Sorrento (SRNE)'s TNK Therapeutics Subsidiary To Acquire Virttu Biologics 11/17/2016 7:14:34 AM
12345678910...
//-->